81 related articles for article (PubMed ID: 16468526)
1. Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections?
Wilson SE; Turpin RS; Hu XH; Sullivan E; Mansley EC; Ma L
Am Surg; 2005 Oct; 71(10):816-20. PubMed ID: 16468526
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection.
Carson JG; Turpin RS; Hu H; Ma L; Wilson SE
Surg Infect (Larchmt); 2008 Feb; 9(1):15-21. PubMed ID: 18363464
[TBL] [Abstract][Full Text] [Related]
3. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: ertapenem for complicated intra-abdominal infections.
Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
[TBL] [Abstract][Full Text] [Related]
5. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
Goldstein EJ; Snydman DR
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii29-36. PubMed ID: 15150181
[TBL] [Abstract][Full Text] [Related]
6. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
Tellado JM; Sen SS; Caloto MT; Kumar RN; Nocea G
Scand J Infect Dis; 2007; 39(11-12):947-55. PubMed ID: 17852889
[TBL] [Abstract][Full Text] [Related]
7. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections.
Baré M; Castells X; Garcia A; Riu M; Comas M; Egea MJ
Int J Technol Assess Health Care; 2006; 22(2):242-8. PubMed ID: 16571200
[TBL] [Abstract][Full Text] [Related]
8. The empiric treatment of nosocomial intra-abdominal infections.
Dupont H
Int J Infect Dis; 2007 May; 11 Suppl 1():S1-6. PubMed ID: 17603948
[TBL] [Abstract][Full Text] [Related]
9. Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
Yellin AE; Johnson J; Higareda I; Congeni BL; Arrieta AC; Fernsler D; West J; Gesser R
Am J Surg; 2007 Sep; 194(3):367-74. PubMed ID: 17693284
[TBL] [Abstract][Full Text] [Related]
10. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
[TBL] [Abstract][Full Text] [Related]
11. Concordance of interrater assessments of surgical methods to achieve source control of intra-abdominal infections.
Suding PN; Orrico RP; Johnson SB; Wilson SE
Am J Surg; 2008 Jul; 196(1):70-3. PubMed ID: 18436178
[TBL] [Abstract][Full Text] [Related]
12. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
13. Severe odontogenic infections, part 2: prospective outcomes study.
Flynn TR; Shanti RM; Hayes C
J Oral Maxillofac Surg; 2006 Jul; 64(7):1104-13. PubMed ID: 16781344
[TBL] [Abstract][Full Text] [Related]
14. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
16. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
17. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
18. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
19. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
[TBL] [Abstract][Full Text] [Related]
20. Length of stay: an appropriate quality measure?
Brasel KJ; Lim HJ; Nirula R; Weigelt JA
Arch Surg; 2007 May; 142(5):461-5; discussion 465-6. PubMed ID: 17515488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
